ICS Members Only
Join ICS Sign in
{{CC.VideoPaywalButtonText}} Sign in Sign in
{{CC.VideoPaywalButtonText}} Sign in

To register for this workshop please email reg_ics22@kenes.com

Purchase Gold Pass Register Sign in
Prefer to watch at your own pace, catch up on what you missed or re-watch your favourite sessions?
Extend your access to all state of the art and scientific meeting content for an extra three months, until 13 December 2022.

To purchase the gold pass please email reg_ics22@kenes.com
Restricted Video
Sign in

Engineering for Better Continence and Pelvic Floor Care

  • Round Table Discussion 2
  • Thursday 14th October 2021
  • 17:00 - 18:00 CEST
  • Live Room 1
  • In-Person and online attendees
  • ICS Members OnlyRestricted Video


  1. To understand the principles of regenerating tissue (RT) therapies.
  2. To appreciate hurdles for clinical translation of RT.
  3. To identify mechanisms of action of biomaterials and cell-based therapies, for the treatment of pelvic floor disorders.
  4. To explore current initiatives in developing cell-based therapies for incontinence and pelvic floor dysfunction.

Why is the topic important?

Current therapies for conditions such as stress urinary incontinence and pelvic organ prolapse are limited by high rates of recurrence or surgical complications. Bioengineering is emerging as a new technology for regenerating tissues compromised by injury, disease or ageing. Whilst RT offers the potential of improving treatment outcomes, as with all emerging technologies, it is essential to focus on basic scientific and surgical principles, and avoid underestimating the challenges that lie ahead; both scientific and regulatory in progressing to preclinical proof-of-concept studies and clinical trials. The speakers in this roundtable will critically address these issues and provide the latest investigations in bioengineered therapies for continence and pelvic floor care.

17:00 17:05 Introduction Chris Chapple
17:05 17:20 The development of new biomaterials for treating stress incontinence and pelvic floor weakness. Sheila MacNeil
17:20 17:35 Developing a bioengineered therapy for treating and preventing Pelvic Organ Prolapse Caroline Gargett
17:35 17:50 Clinical trials of cellular therapies for SUI – what have we learnt? Michael Chancellor
17:50 18:00 Discussion All

This session will be followed by an ICS Live Lounge at 18:00 BST

Enter the Live Lounge

22/06/2024 02:48:50